scispace - formally typeset
M

Mitchell R. O’Connell

Researcher at University of Rochester

Publications -  30
Citations -  2848

Mitchell R. O’Connell is an academic researcher from University of Rochester. The author has contributed to research in topics: RNA & CRISPR. The author has an hindex of 14, co-authored 21 publications receiving 2096 citations. Previous affiliations of Mitchell R. O’Connell include University of California, Berkeley & University of Sydney.

Papers
More filters
Journal ArticleDOI

Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection

TL;DR: It is shown that bacterial C2c2 possesses a unique RNase activity responsible for CRISPR RNA maturation that is distinct from its RNA-activated single-stranded RNA degradation activity.
Journal ArticleDOI

Programmable RNA recognition and cleavage by CRISPR/Cas9

TL;DR: It is shown that Cas9 binds with high affinity to single-stranded RNA targets matching the Cas9-associated guide RNA sequence when the PAM is presented in trans as a separate DNA oligonucleotide, revealing a fundamental connection between PAM binding and substrate selection by Cas9 and highlighting the utility of Cas9 for programmable transcript recognition without the need for tags.
Journal ArticleDOI

Programmable RNA Tracking in Live Cells with CRISPR/Cas9

TL;DR: It is demonstrated that nuclease-inactive S. pyogenes CRISPR/Cas9 can bind RNA in a nucleic-acid-programmed manner and allow endogenous RNA tracking in living cells and establishes RCas9 as a means to track RNA inliving cells in a programmable manner without genetically encoded tags.
Journal ArticleDOI

RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes

TL;DR: It is found that Cas13a pre-crRNA processing is not essential for ssRNA cleavage, although it enhances ssRNA targeting for crRNAs encoded internally within the CRISPR array.
Journal ArticleDOI

Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.

TL;DR: This review will compare and contrast what is known about the molecular architecture and behavior of Type VI (A-D) CRISPR-Cas13 interference complexes, how this allows them to carry out their RNA-targeting function, how Type VI accessory proteins are able to modulate Cas13 activity, and how together all of these features have led to the rapid development of a range of RNA- targeting applications.